About 1 400 reports

  • CHRONIC PAIN
  • 3.2.2.1. CLASSIFICATION OF CHRONIC PAIN

CHRONIC PAIN AND MENTAL HEALTH ##. ##. ##. ##. ##. ##. ##. ##. ##. ##. ##. ##. ##. ##. ##. ##.

  • Pathology
  • North America
  • United States
  • Eli Lilly & Co.
  • Grunenthal GmbH

On the basis of its application, the global nerve stimulators market is classified into depression, chronic pain, dystonia, Parkinson’s disease, epilepsy, and others.

  • Pathology
  • United States
  • Demand
  • Chronic Pain
  • Chronic Pain

The Medical Cannabis Market for Chronic Pain in North America perceived the value of USD ##. ## million in 2014 and USD Pain is the chief reason behind the employment of cannabis in medicines so as to provide relief to the patients suffering from various kind of

  • Marijuana
  • Pathology
  • World
  • Market Size
  • Canopy Growth Corporation

Chronic Pain Phase ## Clinical Trials, 2016 ##.

  • Pathology
  • France
  • United States
  • Market Shares
  • Market Size
  • Fighting Acute And Chronic Pain With Innovative Technology
  • Expansion Of Coverage For Podiatry Services

At least one in four older people are affected by chronic foot pain, influencing their mobility and quality of life. xxii Access to healthcare services and availability of skilled podiatrists will drive the market in the future.

  • Dermatological Condition
  • Diabetes
  • Health Services
  • Hospital
  • Pathology
  • Fighting Acute And Chronic Pain With Innovative Technology
  • Expansion Of Coverage For Podiatry Services

At least one in four older people are affected by chronic foot pain, influencing their mobility and quality of life. xxii Access to healthcare services and availability of skilled podiatrists will drive the market in the future.

  • Dermatological Condition
  • Diabetes
  • Health Services
  • Hospital
  • Pathology

Chronic Neuropathic Pain KOL Survey Biomedtracker performed a ##-question survey of ## United States neurologists who currently treat patients with chronic neuropathic pain and prescribe opioids to at least some of their patients with chronic neuropathic

  • Chronic Disease
  • Chronic Pain
  • Pathology
  • United States

Opioids are considered one of the most effective drug classes for the treatment of chronic pain.

  • Chronic Pain
  • Pathology
  • North America
  • World
  • Market Size
  • shows the etiology of chronic pain.
  • Typically chronic

Tsuda, M. et al. (2013) ' Microglia and intractable chronic pain', Glia, ##(##), pp. ##-##. doi: ##. ##/ glia. ##.

  • Pathology
  • United States
  • World
  • Merck & Co., Inc.
  • Pfizer Inc.
  • U.S. PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION (2018) ($MN), CAGR (%)
  • 10.9.4 KEY DEVELOPMENTS

ACCORDING TO PAIN ALLIANCE EUROPE, ONE OUT OF FIVE EUROPEANS ARE SUFFERING FROM CHRONIC PAIN AND IT CONSIDERED AS ONE OF THE MAIN CAUSES OF DISABILITY, WITH CONSIDERABLE NEGATIVE EFFECTS ON PRODUCTIVITY AT WORK.

  • Analgesic
  • Pathology
  • Surgery
  • Surgical Equipment
  • Therapy
  • 7.4 St. Jude Medical Inc.

Home Healthcare ##.

  • Pathology
  • World
  • Asahi Kasei Corporation
  • Boston Scientific Corporation
  • Jude Medical, Inc.
  • SCS DEVICES MARKET FOR CHRONIC PAIN IN AUSTRALIA, CONSERVATIVE,
  • SCS DEVICES MARKET FOR CHRONIC PAIN IN CHINA, CONSERVATIVE,

EXAMPLE HIGHLIGHTS ##.

  • Mental Health
  • Pathology
  • World

Chronic Pain Phase ## Clinical Trials, 2016 ##.

  • Pathology
  • France
  • Germany
  • Market Shares
  • Market Size

Chronic Pain Phase ## Clinical Trials, 2016 ##.

  • Chronic Pain
  • Pathology
  • Japan
  • Market Shares
  • Market Size

Chronic Pain Phase ## Clinical Trials, 2016 ##.

  • Chronic Pain
  • Pathology
  • United States
  • Market Shares
  • Market Size

Chronic Pain Phase ## Clinical Trials, 2016 ##.

  • Chronic Pain
  • Pathology
  • United Kingdom
  • Market Shares
  • Market Size

Chronic Pain Phase ## Clinical Trials, 2016 ##.

  • Chronic Pain
  • Pathology
  • Italy
  • Market Shares
  • Market Size

Chronic Pain Phase ## Clinical Trials, 2016 ##.

  • Chronic Pain
  • Pathology
  • Germany
  • Market Shares
  • Market Size

Chronic Pain Phase ## Clinical Trials, 2016 ##.

  • Chronic Pain
  • Pathology
  • France
  • Market Shares
  • Market Size

Chronic Pain Phase ## Clinical Trials, 2016 ##.

  • Chronic Pain
  • Pathology
  • Spain
  • Market Shares
  • Market Size
  • PRODUCT PROFILE - LYRICA
  • 4.1 OVERVIEW

Chronic Pain Syndromes.

  • Pathology
  • Forecast
  • Daiichi Sankyo Company
  • Depomed, Inc.
  • Pfizer Inc.
  • 5.1 CHRONIC PAIN NEUROMODULATION MARKET AND FORECAST
  • GLOBAL - FORECAST FOR CHRONIC PAIN NEUROMODULATION MARKET (MILLION US$), 2016 - 2021

The prevalence of chronic back pain is one of the key drivers of the SCS market.

  • Pathology
  • World
  • Boston Scientific Corporation
  • Cyberonics, Inc.
  • Jude Medical, Inc.
  • 13.4.4 Product/Services Portfolio
  • 13.4 2MORROW INC. 13.4.1 Key Facts

The company engaged to provide services for smoking cessation, weight, stress/ anxiety and chronic pain and offer programs including SmartQuit, weight management program, stress (and anxiety) program and chronic pain program.

  • Pathology
  • World
  • Forecast
  • Market Size
  • 2Morrow Inc.

Healthcare providers recommend a urinalysis test in case of back pain, abdominal pain, painful urination and blood in the urine.

  • Autoimmune Disease
  • Diagnostics
  • Healthcare
  • Laboratory
  • Pathology

Deep Brain Stimulation Device Market Size, Outlook and Growth Opportunities, 2019- 2025 ##.

  • Mental Health
  • Pathology
  • APAC
  • World
  • Market Size

Brain Implants Market Size, Outlook and Growth Opportunities, 2019- 2025 ##.

  • Mental Health
  • Pathology
  • APAC
  • World
  • Market Size
  • Comparison by application
  • Global wearable pain management devices market - Year over year growth 2018-2022 (%)

As of 2015, approximately ##% of American adults have significant chronic pain or severe pain.

  • Pathology
  • Fitbit, Inc.
  • Garmin Ltd.
  • Omron Corporation
  • Sonova Holding AG
  • 12.1 BIBLIOGRAPHY

THE STUDY WAS CONDUCTED IN PEOPLE AGES ##-## YEARS WITH CHRONIC BACK PAIN, FROM ## US RHEUMATOLOGIST PRACTICES DURING 1985-2011.

  • Pathology
  • United States
  • Forecast
  • Novartis AG
  • Pfizer Inc.
  • Neurostimulation devices are available for a wide number of applications such as chronic pain, epilepsy, sleep apnea and
  • Neurostimulation Devices

Cost of pharmaceutical treatment for chronic pain is very pain.

  • Pathology
  • World
  • Boston Scientific Corporation
  • Integra LifeSciences Holdings Corporation
  • Jude Medical, Inc.
  • 7.2 SURGICAL APPLICATIONS

ACCORDING TO THE NATIONAL CENTER FOR COMPLEMENTARY AND INTEGRATIVE HEALTH, CLOSE TO ##% OF ADULTS IN THE US EXPERIENCED CHRONIC PAIN AND ##% HAD HIGH-IMPACT CHRONIC PAIN IN 2016.

  • Pathology
  • North America
  • United States
  • CooperSurgical, Inc.
  • Medtronic, Inc.